Global Plasma Fractionation Components Market Size, Share, Growth Analysis, Report 2025-2030

The Global Plasma Fractionation Components Market size was valued at aroundUSD 31.18billion in 2024and is projected to reachUSD 42.39billion by 2030. Along with this, the market is estimated to grow at aCAGR of around 5.51%during the forecast period, i.e., 2025-30. According to MarkNtel Advisors Study.

Global Plasma Fractionation Components Market Driver:

Escalating Geriatric Population Driving the Demand for Plasma-derived Therapies Globally, the surging geriatric population has resulted in a substantial boost in the incidences of diseases like immunodeficiency, neurological disorders, etc., which require plasma-derived therapies for treatment. The increment in the geriatric population has been attributed to the increasing life expectancy of the elderly population in various countries like China, Japan, etc., as a result of their improved healthcare infrastructure. Consequently, as the number of geriatric patients has been increasing, there has been an enhanced demand for plasma-derived therapeutic products, presenting a strong market situation for plasma fractionation manufacturers, particularly immunoglobulins and coagulation factors during historical years.

Further, in response to this growing demand on a global scale, companies specializing in plasma fractionation have proactively started investing in expanding their plasma therapy manufacturing facilities. Such strategic initiatives by companies across the world position them to better address the increasing need for improved treatment, ultimately contributing to positive growth of the Plasma Fractionation Market.

Download a free sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/plasma-fractionation-market.html

Key Market Reports Highlights

Market Dimensions & Projections

Pricing Evaluation

Recent Strategic Moves by Companies

Primary Stakeholders

Import/Export Trend Analysis

Competitive Landscape Assessment

Emerging Opportunities

Market Trends and Indicators

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Browse Full Report including(TOC+ List of Table and Figures): https://www.marknteladvisors.com/research-library/plasma-fractionation-market.html

Global Plasma Fractionation Components Market Segmentation:

The market report categorizes the market based on different segments and geographical analysis.

Study Timeline:

-Base Year: 2024

-Historical Period: 2020 to 2023

-Forecast Period: 2025 to 2030

• By Product

• Immunoglobulin- Market Size & Forecast 2020-2030, (USD Million)

• Intravenous Immunoglobulin- Market Size & Forecast 2020-2030, (USD Million)

• Subcutaneous Immunoglobulin- Market Size & Forecast 2020-2030, (USD Million)

• Other Disease Specific Immunoglobulins (Hepatitis B Immunoglobulin, Tetanus Immunoglobulin, etc.) - Market Size & Forecast 2020-2030, (USD Million)

• Coagulation Factors- Market Size & Forecast 2020-2030, (USD Million)

• Factor VIII- Market Size & Forecast 2020-2030, (USD Million)

• Factor IX- Market Size & Forecast 2020-2030, (USD Million)

• Von Willebrand Factor (vWF) - Market Size & Forecast 2020-2030, (USD Million)

• Prothrombin Complex Concentrates- Market Size & Forecast 2020-2030, (USD Million)

• Fibrinogen Concentrates- Market Size & Forecast 2020-2030, (USD Million)

• Factor XIII- Market Size & Forecast 2020-2030, (USD Million)

• Others (Factor VIIa, Factor XI, etc.)- Market Size & Forecast 2020-2030, (USD Million)

• Albumin- Market Size & Forecast 2020-2030, (USD Million)

• Protease Inhibitor- Market Size & Forecast 2020-2030, (USD Million)

• Others (Plasminogen, Antithrombin III, etc.) - Market Size & Forecast 2020-2030, (USD Million)

• By Application

• Neurology- Market Size & Forecast 2020-2030, (USD Million)

• Immunology- Market Size & Forecast 2020-2030, (USD Million)

• Hematology- Market Size & Forecast 2020-2030, (USD Million)

• Critical Care- Market Size & Forecast 2020-2030, (USD Million)

• Pulmonology- Market Size & Forecast 2020-2030, (USD Million)

• Rheumatology- Market Size & Forecast 2020-2030, (USD Million)

• Others (Oncology, Pediatrics, etc.) - Market Size & Forecast 2020-2030, (USD Million)

• By End User

• Hospitals - Market Size & Forecast 2020-2030, (USD Million)

• Specialty Clinics- Market Size & Forecast 2020-2030, (USD Million)

• Research Facilities - Market Size & Forecast 2020-2030, (USD Million)

• By Region

• North America

• South America

• Europe

• The Middle East & Africa

• Asia-Pacific

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including - Biotest A.G., Octapharma A.G., Adma Biologics, Aegros, CSL Limited, Grifols S.A., Kedrion Biopharma Inc., Bio Products Laboratory Ltd, Takeda Pharmaceuticals, Emergent Bio Solutions, Intas Pharmaceutical, Plasma Gen Biosciences, S K Plasma, Australian Red Cross Lifeblood, and Others are looking forward to strengthening their market positions.

Have questions? Our consultant is ready to assist: https://www.marknteladvisors.com/query/talk-to-our-consultant/plasma-fractionation-market.html

Global Plasma Fractionation Components Industry Recent Development:

In 2023, Octapharma AG received expanded FDA approval for its plasma-based product, wilate, for routine prophylaxis to reduce bleeding episodes in adults and children aged six and older.

In 2023, Grifols, S.A. obtained FDA approval for a new immunoglobulin purification and filling facility in North Carolina, boosting its production capacity by an additional 16 million grams of plasma therapy annually.

In 2023: Bio Products Laboratory (BPL) announced the establishment of a strategic partnership with CSI Pharmacy to offer distribution rights to BPLs immune globulin product Gammaplex.

In 2022: CSL invested USD 900 million to open a new plasma fractionation facility to manufacture plasma-fractionated drugs for treating hemophilia, immune system problems, burns, and other life-threatening medical conditions in Australia.

Data-Driven Insights Backed by Proven Research

We follow a tried-and-tested research methodology that blends top-down and bottom-up approaches to deliver highly accurate market insights. Every report is powered by data triangulation, ensuring well-rounded and validated findings.

From smart sample selection and reliable data collection to in-depth analysis and precise forecasting, our process is designed to minimize error and maximize impact.

About Us

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Us

MarkNtel Advisors

Email: sales@marknteladvisors.com

Website: www.marknteladvisors.com

Latest Press Release - https://www.marknteladvisors.com/press-release